These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 25974386)
1. Cysteine-Functionalized Nanostructured Lipid Carriers for Oral Delivery of Docetaxel: A Permeability and Pharmacokinetic Study. Fang G; Tang B; Chao Y; Xu H; Gou J; Zhang Y; Xu H; Tang X Mol Pharm; 2015 Jul; 12(7):2384-95. PubMed ID: 25974386 [TBL] [Abstract][Full Text] [Related]
2. Docetaxel-nicotinamide complex-loaded nanostructured lipid carriers for transdermal delivery. Fan X; Chen J; Shen Q Int J Pharm; 2013 Dec; 458(2):296-304. PubMed ID: 24177313 [TBL] [Abstract][Full Text] [Related]
3. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Li H; Chen M; Su Z; Sun M; Ping Q Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421 [TBL] [Abstract][Full Text] [Related]
4. Core-matched encapsulation of an oleate prodrug into nanostructured lipid carriers with high drug loading capability to facilitate the oral delivery of docetaxel. Sun B; Luo C; Li L; Wang M; Du Y; Di D; Zhang D; Ren G; Pan X; Fu Q; Sun J; He Z Colloids Surf B Biointerfaces; 2016 Jul; 143():47-55. PubMed ID: 27011346 [TBL] [Abstract][Full Text] [Related]
5. Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers. Tian C; Asghar S; Wu Y; Chen Z; Jin X; Yin L; Huang L; Ping Q; Xiao Y Int J Nanomedicine; 2017; 12():7897-7911. PubMed ID: 29138557 [TBL] [Abstract][Full Text] [Related]
6. Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption. Zhou X; Zhang X; Ye Y; Zhang T; Wang H; Ma Z; Wu B Int J Pharm; 2015 Feb; 479(2):391-8. PubMed ID: 25556104 [TBL] [Abstract][Full Text] [Related]
7. Preparation and pharmacokinetics of docetaxel based on nanostructured lipid carriers. Li X; Wang D; Zhang J; Pan W J Pharm Pharmacol; 2009 Nov; 61(11):1485-92. PubMed ID: 19903373 [TBL] [Abstract][Full Text] [Related]
8. RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells. Lee SG; Kim CH; Sung SW; Lee ES; Goh MS; Yoon HY; Kang MJ; Lee S; Choi YW Int J Nanomedicine; 2018; 13():3263-3278. PubMed ID: 29910614 [TBL] [Abstract][Full Text] [Related]
9. Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides. Yang G; Wu F; Chen M; Jin J; Wang R; Yuan Y Int J Nanomedicine; 2019; 14():2267-2280. PubMed ID: 31015758 [TBL] [Abstract][Full Text] [Related]
10. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers. Wang W; Chen L; Huang X; Shao A AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090 [TBL] [Abstract][Full Text] [Related]
11. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin. Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882 [TBL] [Abstract][Full Text] [Related]
12. Effect of cell-penetrating peptide-coated nanostructured lipid carriers on the oral absorption of tripterine. Chen Y; Yuan L; Zhou L; Zhang ZH; Cao W; Wu Q Int J Nanomedicine; 2012; 7():4581-91. PubMed ID: 22942642 [TBL] [Abstract][Full Text] [Related]
13. Development of novel rosuvastatin nanostructured lipid carriers for oral delivery in an animal model. Li J; Yang M; Xu W Drug Des Devel Ther; 2018; 12():2241-2248. PubMed ID: 30050285 [TBL] [Abstract][Full Text] [Related]
14. Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide. Zhang T; Chen J; Zhang Y; Shen Q; Pan W Eur J Pharm Sci; 2011 Jun; 43(3):174-9. PubMed ID: 21530654 [TBL] [Abstract][Full Text] [Related]
15. N-acetyl-L-cysteine functionalized nanostructured lipid carrier for improving oral bioavailability of curcumin: preparation, in vitro and in vivo evaluations. Tian C; Asghar S; Wu Y; Kambere Amerigos D; Chen Z; Zhang M; Yin L; Huang L; Ping Q; Xiao Y Drug Deliv; 2017 Nov; 24(1):1605-1616. PubMed ID: 29063815 [TBL] [Abstract][Full Text] [Related]
16. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy? Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462 [TBL] [Abstract][Full Text] [Related]
17. Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride. Ranpise NS; Korabu SS; Ghodake VN Colloids Surf B Biointerfaces; 2014 Apr; 116():81-7. PubMed ID: 24445002 [TBL] [Abstract][Full Text] [Related]
18. Nanostructured lipid carriers as oral delivery systems for improving oral bioavailability of nintedanib by promoting intestinal absorption. Zhu Y; Liang X; Lu C; Kong Y; Tang X; Zhang Y; Yin T; Gou J; Wang Y; He H Int J Pharm; 2020 Aug; 586():119569. PubMed ID: 32592899 [TBL] [Abstract][Full Text] [Related]
19. Mucoadhesive nanostructured lipid carriers (NLCs) as potential carriers for improving oral delivery of curcumin. Chanburee S; Tiyaboonchai W Drug Dev Ind Pharm; 2017 Mar; 43(3):432-440. PubMed ID: 27808665 [TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid-coated cationic nanostructured lipid carriers for oral vincristine sulfate delivery. Gao X; Zhang J; Xu Q; Huang Z; Wang Y; Shen Q Drug Dev Ind Pharm; 2017 Apr; 43(4):661-667. PubMed ID: 28043185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]